Literature DB >> 26879513

Assessing medication role on neuropathological findings in Parkinson's disease.

Charles H Adler1, Joseph G Hentz2, Thomas G Beach3.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 26879513      PMCID： PMC4861676          DOI： 10.1002/mds.26536

Source DB:  PubMed          Journal:  Mov Disord        ISSN： 0885-3185            Impact factor:   10.338


× No keyword cloud information.
  9 in total

1.  Alpha-synuclein cortical Lewy bodies correlate with dementia in Parkinson's disease.

Authors:  H I Hurtig; J Q Trojanowski; J Galvin; D Ewbank; M L Schmidt; V M Lee; C M Clark; G Glosser; M B Stern; S M Gollomp; S E Arnold
Journal:  Neurology       Date:  2000-05-23       Impact factor: 9.910

2.  Parkinson disease neuropathology: later-developing dementia and loss of the levodopa response.

Authors:  Hulya Apaydin; J Eric Ahlskog; Joseph E Parisi; Bradley F Boeve; Dennis W Dickson
Journal:  Arch Neurol       Date:  2002-01

3.  Neuropathology of dementia in Parkinson's disease: a prospective, community-based study.

Authors:  Dag Aarsland; Robert Perry; Andrew Brown; Jan P Larsen; Clive Ballard
Journal:  Ann Neurol       Date:  2005-11       Impact factor: 10.422

4.  Concomitant pathologies among a spectrum of parkinsonian disorders.

Authors:  Brittany N Dugger; Charles H Adler; Holly A Shill; John Caviness; Sandra Jacobson; Erika Driver-Dunckley; Thomas G Beach
Journal:  Parkinsonism Relat Disord       Date:  2014-02-22       Impact factor: 4.891

5.  Are there differences in cerebral white matter lesion burdens between Parkinson's disease patients with or without dementia?

Authors:  Sun-Ah Choi; Virgilio Gerald Hilario Evidente; John N Caviness; Holly A Shill; Marwan N Sabbagh; Donald J Connor; Joseph G Hentz; Charles H Adler; Thomas G Beach
Journal:  Acta Neuropathol       Date:  2009-12-03       Impact factor: 17.088

6.  Unified staging system for Lewy body disorders: correlation with nigrostriatal degeneration, cognitive impairment and motor dysfunction.

Authors:  Thomas G Beach; Charles H Adler; LihFen Lue; Lucia I Sue; Jyothi Bachalakuri; Jonette Henry-Watson; Jeanne Sasse; Sarah Boyer; Scophil Shirohi; Reed Brooks; Jennifer Eschbacher; Charles L White; Haru Akiyama; John Caviness; Holly A Shill; Donald J Connor; Marwan N Sabbagh; Douglas G Walker
Journal:  Acta Neuropathol       Date:  2009-04-28       Impact factor: 17.088

7.  Parkinson disease with dementia: comparing patients with and without Alzheimer pathology.

Authors:  Marwan N Sabbagh; Charles H Adler; Tyson J Lahti; Donald J Connor; Linda Vedders; Lars K Peterson; John N Caviness; Holly A Shill; Lucia I Sue; Iryna Ziabreva; Elaine Perry; Clive G Ballard; Dag Aarsland; Douglas G Walker; Thomas G Beach
Journal:  Alzheimer Dis Assoc Disord       Date:  2009 Jul-Sep       Impact factor: 2.703

8.  The Sydney multicenter study of Parkinson's disease: the inevitability of dementia at 20 years.

Authors:  Mariese A Hely; Wayne G J Reid; Michael A Adena; Glenda M Halliday; John G L Morris
Journal:  Mov Disord       Date:  2008-04-30       Impact factor: 10.338

9.  Prevalence of Hippocampal Sclerosis in a Clinicopathologically Characterized Cohort.

Authors:  Michael Malek-Ahmadi; Vickram Kahlon; Charles H Adler; Aleksandra Obradov; Kabir Thind; Holly A Shill; Lucia I Sue; John N Caviness; Sandra Jacobson; Marwan N Sabbagh
Journal:  Clin Exp Med Sci       Date:  2013
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.